Demonstrates ultrasensitive melatonin detection in dietary supplements, suggesting improved accuracy in analysis.
A novel electrochemical sensing platform based on a glassy carbon electrode (GCE) modified with a juglone/mesoporous carbon composite (JUG-MC/GCE) was developed for the ultrasensitive determination of melatonin (MEL) in pharmaceutical formulations and dietary supplements. Incorporation of juglone and mesoporous carbon within the coating deposited on the glassy carbon electrode, resulted in enhanced charge-transfer characteristics at the electrode–electrolyte interface. Under optimized differential pulse voltammetry (DPV) conditions in a 0.1 mol L−1 McIlvaine buffer (pH 2.8), the proposed sensor demonstrated an exceptional electrocatalytic response for melatonin oxidation via a two-electron, one-proton irreversible pathway under kinetic control. The analytical performance reveal multiple linear calibration intervals with an ultra-low limit of detection (LOD) of 0.21 µg L−1 (0.9 nM). The sensor manifested robust operational repeatability (RSD ≤ 1.8%), long-term storage stability, and satisfactory selectivity toward melatonin in the presence of common tablet excipients and selected potential interferents. The practical utility of the JUG-MC/GCE platform was successfully validated through the direct quantification of melatonin in commercial tablets, capsules, and complex jelly matrices, confirming its suitability for melatonin determination in real samples.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: